
Conformis CFMS
Quarterly report 2023-Q2
added 05-16-2026
Conformis Interest Expense 2011-2026 | CFMS
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Conformis
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.02 M | 3.5 M | 2.37 M | 2.94 M | 3.36 M | 2.12 M | 138 K | 1.38 M | 360 K | 642 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.5 M | 138 K | 1.88 M |
Quarterly Interest Expense Conformis
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 668 K | 637 K | - | 526 K | 453 K | 451 K | - | 601 K | 607 K | 594 K | - | 611 K | 584 K | 574 K | - | 573 K | 1.34 M | 453 K | - | 788 K | 766 K | 735 K | - | 718 K | 372 K | 307 K | - | 4 K | 75 K | 25 K | - | 911 K | 245 K | 223 K | - | 89 K | 38 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.34 M | 4 K | 499 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | - | - | $ 162 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
624 K | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 13.42 | -0.15 % | $ 380 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 8.32 | 0.42 % | $ 1.25 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.77 | 14.93 % | $ 39 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 79.66 | 0.34 % | $ 4.35 B | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.33 | -2.92 % | $ 54.1 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.74 | -0.45 % | $ 416 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 11.9 | 1.54 % | $ 426 M | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 9.33 | 0.19 % | $ 369 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
LENSAR
LNSR
|
636 K | $ 5.78 | -0.69 % | $ 69.1 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
455 K | $ 38.5 | 2.31 % | $ 325 M | ||
|
MiMedx Group
MDXG
|
-558 K | $ 3.7 | 2.64 % | $ 547 M | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 6.98 | 5.36 % | $ 211 M | ||
|
Butterfly Network
BFLY
|
2.77 M | $ 5.6 | 1.08 % | $ 1.38 B | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
-668 K | $ 1.34 | 16.09 % | $ 56.1 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 77.27 | -3.88 % | $ 10.4 B | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 149.63 | -0.05 % | $ 10.5 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 34.54 | -0.66 % | $ 1.07 B | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 41.16 | -3.61 % | $ 1.21 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 90.81 | -0.19 % | $ 3.15 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 84.95 | -0.19 % | $ 49.7 B | ||
|
TransMedics Group
TMDX
|
3.87 M | $ 75.61 | 3.7 % | $ 2.57 B |